Yuze Wu

Expression and significance of VEGF , CD 34 , Ki-67 and p 21 in pterygium

Hai Li, Yi Wang, Kai Q. Wu, 2022 .

Increased expression of ECT2 predicts the poor prognosis of breast cancer patients

Kongming Wu, B. Song, Mengke Niu, 2022, Experimental Hematology & Oncology.

Recent advances in targeted strategies for triple-negative breast cancer

Kongming Wu, Ming Yi, Shuangli Zhu, 2023, Journal of Hematology & Oncology.

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy

Jing Zhang, Lijuan Lyu, Mengke Niu, 2023, Journal of Hematology & Oncology.

Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors

Mengke Niu, Ming Yi, Kongming Wu, 2024, Cancer communications.

Targeting cytokine and chemokine signaling pathways for cancer therapy

Mengke Niu, Kongming Wu, Zhi-tang Dai, 2024, Signal transduction and targeted therapy.

S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1

Mengke Niu, Ming Yi, Kongming Wu, 2023, Biomarker research.